Business Description
Genetics Generation Advancement Corp
NAICS : 621498
ISIN : TW0004160007
Description
Genetics Generation Advancement Corp is a Taiwan based company specialized in genetic testing and scientific information. It is engaged in providing services for the detection of genetic defects and prevention in newborns. Their main services include amniotic fluid chromosome chip screening, pre-implantation genetic diagnosis, and Molecular DNA testing diagnostics. The company is focused on the major areas of maternal precision medicine, pediatric disease diagnosis, drug-associated diagnosis, non-invasive cancer detection and precise health management. The business units of the company are Genetic testing unit and Informatics business unit.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 9.88 | |||||
| Equity-to-Asset | 0.76 | |||||
| Debt-to-Equity | 0.08 | |||||
| Debt-to-EBITDA | 0.48 | |||||
| Interest Coverage | 114.57 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 7.93 | |||||
| Beneish M-Score | -2.57 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10 | |||||
| 3-Year FCF Growth Rate | 113.6 | |||||
| 3-Year Book Growth Rate | 11.2 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 24.85 | |||||
| 9-Day RSI | 26.01 | |||||
| 14-Day RSI | 29.91 | |||||
| 6-1 Month Momentum % | -18.45 | |||||
| 12-1 Month Momentum % | 126.08 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.29 | |||||
| Quick Ratio | 3.04 | |||||
| Cash Ratio | 2.37 | |||||
| Days Inventory | 34.46 | |||||
| Days Sales Outstanding | 53.88 | |||||
| Days Payable | 45.83 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.73 | |||||
| Dividend Payout Ratio | 0.23 | |||||
| 3-Year Dividend Growth Rate | -9.7 | |||||
| Forward Dividend Yield % | 0.73 | |||||
| 5-Year Yield-on-Cost % | 0.73 | |||||
| Shareholder Yield % | -0.53 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 42.59 | |||||
| Operating Margin % | 8.42 | |||||
| Net Margin % | 8.8 | |||||
| FCF Margin % | 10.66 | |||||
| ROE % | 11.77 | |||||
| ROA % | 8.9 | |||||
| ROIC % | 24.24 | |||||
| ROC (Joel Greenblatt) % | 126.37 | |||||
| ROCE % | 14.34 | |||||
| Years of Profitability over Past 10-Year | 6 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 31.58 | |||||
| PE Ratio without NRI | 31.59 | |||||
| Shiller PE Ratio | 221.13 | |||||
| Price-to-Owner-Earnings | 24.08 | |||||
| PS Ratio | 2.79 | |||||
| PB Ratio | 3.2 | |||||
| Price-to-Tangible-Book | 3.32 | |||||
| Price-to-Free-Cash-Flow | 26.1 | |||||
| Price-to-Operating-Cash-Flow | 18.67 | |||||
| EV-to-EBIT | 20.12 | |||||
| EV-to-EBITDA | 16.24 | |||||
| EV-to-Revenue | 2.2 | |||||
| EV-to-FCF | 20.6 | |||||
| Price-to-Projected-FCF | 2.64 | |||||
| Price-to-Median-PS-Value | 1.53 | |||||
| Price-to-Graham-Number | 2.16 | |||||
| Price-to-Net-Current-Asset-Value | 4.53 | |||||
| Price-to-Net-Cash | 7.64 | |||||
| Earnings Yield (Greenblatt) % | 4.97 | |||||
| FCF Yield % | 3.85 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genetics Generation Advancement Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil NT$) | 664.368 | ||
| EPS (TTM) (NT$) | 2.185 | ||
| Beta | 1.08 | ||
| Volatility % | 90.07 | ||
| 14-Day RSI | 29.91 | ||
| 14-Day ATR (NT$) | 2.727726 | ||
| 20-Day SMA (NT$) | 76.985 | ||
| 12-1 Month Momentum % | 126.08 | ||
| 52-Week Range (NT$) | 36.169916 - 150.866625 | ||
| Shares Outstanding (Mil) | 26.69 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genetics Generation Advancement Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genetics Generation Advancement Corp Stock Events
| Event | Date | Price(NT$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genetics Generation Advancement Corp Frequently Asked Questions
What is Genetics Generation Advancement Corp(ROCO:4160)'s stock price today?
The current price of ROCO:4160 is NT$69.00. The 52 week high of ROCO:4160 is NT$150.87 and 52 week low is NT$36.17.
When is next earnings date of Genetics Generation Advancement Corp(ROCO:4160)?
The next earnings date of Genetics Generation Advancement Corp(ROCO:4160) is .
Does Genetics Generation Advancement Corp(ROCO:4160) pay dividends? If so, how much?
The Dividend Yield %  of Genetics Generation Advancement Corp(ROCO:4160) is 0.73% (As of Today), Highest Dividend Payout Ratio of Genetics Generation Advancement Corp(ROCO:4160) was 0.83. The lowest was 0.23. And the median was 0.51. The  Forward Dividend Yield % of Genetics Generation Advancement Corp(ROCO:4160) is 0.73%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers